Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCellectis Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.34 | -$0.20 | -$0.26 |
| Q2 2026 | 5 | -$0.32 | -$0.17 | -$0.25 |
| Q3 2026 | 5 | -$0.30 | -$0.19 | -$0.23 |
| Q4 2026 | 1 | -$0.27 | -$0.11 | -$0.20 |
| Q1 2027 | 1 | -$0.54 | -$0.22 | -$0.40 |
| Q2 2027 | 1 | -$0.61 | -$0.25 | -$0.45 |
| Q3 2027 | 1 | -$0.09 | -$0.04 | -$0.07 |
| Q4 2027 | 1 | -$0.02 | -$0.01 | -$0.01 |
Cellectis Earnings Date And Information
Cellectis last posted its earnings results on Monday, May 11th, 2026. The company reported $-0.18 earnings per share for the quarter, topping analysts' consensus estimates of $-0.25833 by $0.07833. The company had revenue of 5.80 M for the quarter and had revenue of 72.95 M for the year. Cellectis has generated $-1 earnings per share over the last year ($-0.68 diluted earnings per share) and currently has a price-to-earnings ratio of -6.22. Cellectis has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Cellectis Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/11/2026 | Q1 2026 | -$0.26 | -$0.18 | 0.08 | $11.04 M | $5.80 M |
| 03/19/2026 | Q4 2025 | N/A | -$0.27 | N/A | $13.39 M | $10.40 M |
| 11/07/2025 | Q3 2025 | -$0.10 | $0.01 | 0.11 | $9.55 M | $35.17 M |
| 08/04/2025 | Q2 2025 | -$0.10 | -$0.24 | -0.14 | $11.23 M | $16.73 M |
| 05/12/2025 | Q1 2025 | -$0.19 | -$0.18 | 0.01 | $13.83 M | $10.66 M |
| 03/13/2025 | Q4 2024 | N/A | $0.06 | N/A | $9.86 M | $12.72 M |
| 11/04/2024 | Q3 2024 | -$0.20 | -$0.23 | -0.03 | $9.77 M | $16.20 M |
| 08/06/2024 | Q2 2024 | -$0.33 | -$0.28 | 0.05 | $3.70 M | $8.06 M |
| 05/28/2024 | Q1 2024 | N/A | $0.08 | N/A | $3.70 M | $4.53 M |
| 12/31/2023 | Q4 2023 | N/A | -$0.60 | N/A | N/A | $283.00 K |
| 11/06/2023 | Q3 2023 | -$0.36 | -$0.31 | 0.05 | N/A | $155.00 K |
| 08/07/2023 | Q2 2023 | N/A | -$0.19 | N/A | N/A | $178.00 K |
| 05/04/2023 | Q1 2023 | -$0.30 | -$0.58 | -0.28 | N/A | $139.00 K |
| 03/08/2023 | Q4 2022 | -$0.75 | -$0.56 | 0.19 | N/A | $15.91 M |
| 11/03/2022 | Q3 2022 | -$0.58 | -$0.55 | 0.03 | N/A | $176.00 K |
| 06/30/2022 | Q2 2022 | N/A | -$0.42 | N/A | N/A | $1.31 M |
| 05/05/2022 | Q1 2022 | N/A | -$0.70 | N/A | N/A | $1.67 M |
| 03/03/2022 | Q4 2021 | -$1.05 | -$0.89 | 0.16 | N/A | $12.21 M |
| 09/30/2021 | Q3 2021 | N/A | -$0.82 | N/A | N/A | $8.31 M |
| 08/31/2021 | Q2 2021 | N/A | -$0.88 | N/A | N/A | $11.18 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cellectis Earnings: FAQ's
In the previous quarter, Cellectis (:CLLS) reported $-0.18 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.25833 by $0.07833.
The conference call for Cellectis's latest earnings report can be listened to online.
The conference call transcript for Cellectis's latest earnings report can be read online.
Cellectis (:CLLS) has a recorded annual revenue of $72.95 M.
Cellectis (:CLLS) has a recorded net income of $-67,593,000.Cellectis has generated $-0.68 earnings per share over the last four quarters.
Cellectis (:CLLS) has a price-to-earnings ratio of -6.22 and price/earnings-to-growth ratio is 0.07.